Ella Ekholm

Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes

Chantal Mathieu, Aurelian-Emil Ranetti, Danshi Li et al. · Diabetes Care · 2015 · 142 citations

Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes

S. Matthäei, Doina Catrinoiu, Aleksander Celiñski et al. · Diabetes Care · 2015 · 84 citations · Full text

Postprandial Dynamics of Plasma Glucose, Insulin, and Glucagon in Patients with Type 2 Diabetes Treated with Saxagliptin Plus Dapagliflozin Add-On to Metformin Therapy

Lars Hansen, Nayyar Iqbal, Ella Ekholm et al. · Endocrine Practice · 2014 · 61 citations

Metabolic Syndrome, Diabetes Management, Postprandial Dynamics +9

Metabolite Profiling Reveals Normal Metabolic Control in Carriers of Mutations in the Glucokinase Gene (MODY2)

Peter Spégel, Ella Ekholm, Leif Groop et al. · Diabetes · 2012 · 49 citations · Full text

Metabolic Disorder, Metabolomic Profiling, Molecular Biology +24

Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16‐week double‐blind treatment period

Eiichi Araki, Yukiko Onishi, Michiko Asano et al. · Journal of Diabetes Investigation · 2015 · 49 citations · Full text